MedTrace Logo

Dysregulation of Whole-body Metabolism in Ovarian Cancer: A Longitudinal Study

NCT06800105 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 10

Last updated 2025-01-29

No results posted yet for this study

Summary

Minimal information is available regarding changes in whole-body metabolism in ovarian cancer patients, and no study has assessed whole-body lipid metabolism in this patient population. In this pilot study we will assess fasting and postprandial lipid metabolism of ovarian cancer patients before, during, and after treatment via indirect calorimetry.

Conditions

  • Ovary Cancer

Interventions

OTHER

High fat smoothie

Participants will consume a standardized 490 kcal high-fat smoothie, consisting of 57% fat, 23% carbohydrate, and 20% protein.

Sponsors & Collaborators

  • University of Tennessee Graduate School of Medicine

    lead OTHER

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-03-22
Primary Completion
2027-03-31
Completion
2028-03-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06800105 on ClinicalTrials.gov